VITROS Immunodiagnostic Products NT-pro BNP Reagent Pack, REF/Catalog 680 2156, IVD --- Ortho-Clinical Diagnostics Pencoed, Bridgend CF35 5PZ, UK
Publicado el 19 de abril de 2017 · Inicio del retiro: 7 de marzo de 2017
Resumen
FDA registra el retiro Z-1765-2017 de dispositivos médicos de Clase II, publicado el 19 de abril de 2017 e iniciado el 7 de marzo de 2017. Empresa responsable: ORTHO-CLINICAL DIAGNOSTICS; Estado: Finalizado; Cantidad reportada: US: 6324; Foreign: 1868; Lote: Lot 1570 (expiry 22 March 2017), Lot 1580 (expiry 13 April 2017), Lot 1590 (expiry 27 April 2017). La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Increased frequency of calibration failures for VITROS Immunodiagnostic Products NT-proBNP Reagent Lots 1568, 1570, 1580 and 1590, due to background signals for these affected NT-proBNP lots that have been increasing with time since release testing, resulting in higher than expected VITROS Immunodiagnostic Products NT-proBNP level 1 calibrator signals produced, leading to calibration failures.
Qué hacer
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- ORTHO-CLINICAL DIAGNOSTICS
- Distribuidor
- Worldwide: United States, Puerto Rico, Bermuda, Australia, Brazil, Canada, Chile, China, Colombia, England, France, Germany, India, Italy, Japan, Mexico, Panama, Poland, Singapore, Spain, and Venezuela.
- Lote
- Lot 1570 (expiry 22 March 2017), Lot 1580 (expiry 13 April 2017), Lot 1590 (expiry 27 April 2017)
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United Kingdom
Retiros relacionados
- FDACobas 8100 bi-directional reformatter (BRF) module with Software Version 02-xx19 de abril de 2017
- FDAThe PreludeSYNC Radial Compression Device is a sterile, single use disposable device used to assist in gaining19 de abril de 2017
- FDAiConnect Enterprise Archive (ICEA) software. The firm name on the labeling is Merge Healthcare, Hartland, WI.19 de abril de 2017
- FDAVITROS Immunodiagnostic Products TSH Reagent Pack, REF/Catalog Number/Product Code 191 2997, Unique Device24 de agosto de 2016
- FDAVITROS Immunodiagnostic Products Anti-HCV Reagent Pack for in vitro qualitative detection of immunoglobulin G1 de octubre de 2014
- FDAVITROS® Immunodiagnostic Products CA 19-9 Calibrators and Reagent Packs, Lot 1320 VITROS® CA 19-9 Reagent20 de agosto de 2014
Preguntas sobre este retiro
¿VITROS Immunodiagnostic Products NT-pro BNP Reagent Pack, REF/Catalog 680 2156, IVD --- Ortho-Clinical Diagnostics Pencoed, Bridgend CF35 5PZ, UK fue retirado del mercado?
Sí. FDA publicó el retiro Z-1765-2017 el 19 de abril de 2017. Peligro reportado: Increased frequency of calibration failures for VITROS Immunodiagnostic Products NT-proBNP Reagent Lots 1568, 1570, 1580 and 1590, due to background signals for these affected NT-proBNP lots that have been increasing with time since release testing, resulting in higher than expected VITROS Immunodiagnostic Products NT-proBNP level 1 calibrator signals produced, leading to calibration failures.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit